23-25 October 2024

Rockville, MD - USA

The Adolphe Quetelet Society is delighted to invite you to the

Bayesian Biostatistics
Conference Bayes 2024

23-25 October 2024

Rockville, MD – USA

A primary goal of this meeting is to facilitate interaction between statisticians from FDA and industry, to discuss the acceptability of Bayesian methods in regulatory submissions.

This includes discussions of recent FDA programs designed to increase Bayesian content of new drug applications, including the Complex Innovative Trial Design (CID) meeting program, the Bayesian Supplemental Analysis (BSA) demonstration project, the Accelerating Rare disease Cures (ARC) program, and others.